Search for: "Pfizer Inc."
Results 1061 - 1080
of 1,505
Sorted by Relevance
|
Sort by Date
13 May 2010, 12:27 pm
Pfizer, Inc., 675 F. [read post]
3 Apr 2009, 5:10 am
Schulman, 48, Pfizer Inc.Bradford L. [read post]
22 Jun 2014, 9:01 pm
Recently, the news reported that Pfizer, Inc. wants to buy a British rival, AstraZeneca, PLC for nearly $100 billion. [read post]
1 Feb 2007, 6:07 am
Pfizer Inc., 196 F. [read post]
29 Apr 2011, 7:43 am
Pfizer Inc. [read post]
1 Mar 2007, 5:50 am
Pfizer, Inc., 381 F. [read post]
27 Jan 2012, 4:00 am
However, the American company Pfizer Inc., proprietor of the earlier Community trade mark VIAGRA (registered in particular for a drug to treat erectile dysfunction), opposed that application.On the basis on that opposition, OHIM refused to register VIAGUARA as a Community trade mark. [read post]
27 Jan 2018, 6:32 am
Pfizer Guilbeau v. [read post]
19 Mar 2012, 3:57 am
IMS Health, Inc., 131 S. [read post]
27 Aug 2012, 11:01 am
Relying on our decision in Amgen Inc. v. [read post]
11 Jan 2024, 12:03 am
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
17 Sep 2020, 4:55 am
Apple Inc. (9th Cir. 2020): “Employees receive no compensation for the time spent waiting for and undergoing exit searches, because they must clock out before undergoing a search. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
6 Nov 2020, 7:16 am
Mylan is set to merge with Pfizer later this calendar year. [read post]
12 Oct 2011, 8:31 am
See Perfect 10, Inc. v. [read post]
19 Apr 2022, 5:05 am
The Anti-Kickback Statute prohibits offering or accepting kickbacks intended to generate health care business. [read post]
26 Oct 2012, 12:52 pm
Pfizer, Inc., No. 2:09-cv-262, 2012 WL 2970627 (D. [read post]
22 Apr 2014, 11:51 am
Those cases are in conflict with a PTAB decision on the same topic: Ex Parte Pfizer, Inc., 2010 WL 532133 (Bd. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]